Find the Perfect Plan for Your Investment Journey
M
Latest price
52 Week Range
CA$0.02 - CA$0.07
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$10.57M |
EV | CA$8.21M |
Shares Outstanding | 352.44M |
Beta | 0.76 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | - |
EPS | 9.00% |
Operating Cash Flow | 5.10% |
Free Cash Flow | 0.60% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -61.64% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
M
Mountain Valley MD Holdings Inc.
MVMD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Hancock, Dennis
Employees
1
Website
www.mountainvalleymd.comIPO Date
2020-03-02
Headquarters
260 Edgeley Boulevard, Unit 4, Concord, Ontario, L4K 3Y4, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved